Azitra, Inc. (AZTR) stock
AZTRNYSEPharmaceutical PreparationsFiscal year ends December 31
$0.07+0.00 (0.00%)
Close on Oct 19, 2026Market cap $32.20MP/E –Yield –
Azitra free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Azitra's free cash flow for the twelve months ending Jun 30, 2026 was -$11.17M. For fiscal 2025 it was -$11.25M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$11.25M | – |
| FY2024 | Dec 31, 2024 | -$10.19M | – |
| FY2023 | Dec 31, 2023 | -$7.39M | – |
| FY2022 | Dec 31, 2022 | -$8.38M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$3.33M | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.49M | – |
| Q4 FY2025 | Dec 31, 2025 | -$2.90M | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.45M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.83M | – |
| Q1 FY2025 | Mar 31, 2025 | -$3.07M | – |
| Q4 FY2024 | Dec 31, 2024 | -$2.59M | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.48M | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.10M | – |
| Q1 FY2024 | Mar 31, 2024 | -$3.02M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.54M | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.80M | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.73M | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.32M | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.18M | – |
| Q3 FY2022 | Sep 30, 2022 | -$2.08M | – |
See a number that looks wrong?